ZA968525B - Process for the preparation of enantiomerically pure imidazolyl compounds - Google Patents

Process for the preparation of enantiomerically pure imidazolyl compounds

Info

Publication number
ZA968525B
ZA968525B ZA968525A ZA968525A ZA968525B ZA 968525 B ZA968525 B ZA 968525B ZA 968525 A ZA968525 A ZA 968525A ZA 968525 A ZA968525 A ZA 968525A ZA 968525 B ZA968525 B ZA 968525B
Authority
ZA
South Africa
Prior art keywords
addition salt
acid
mixture
enantiomer
compound
Prior art date
Application number
ZA968525A
Other languages
English (en)
Inventor
Paulus Franciscus Corneli Meij
Jan-Maarten Verbeek
Original Assignee
Duphar Int Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Duphar Int Res filed Critical Duphar Int Res
Publication of ZA968525B publication Critical patent/ZA968525B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/06—Peri-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Epoxy Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
ZA968525A 1995-10-13 1996-10-09 Process for the preparation of enantiomerically pure imidazolyl compounds ZA968525B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP95202765 1995-10-13

Publications (1)

Publication Number Publication Date
ZA968525B true ZA968525B (en) 1997-05-20

Family

ID=8220714

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA968525A ZA968525B (en) 1995-10-13 1996-10-09 Process for the preparation of enantiomerically pure imidazolyl compounds

Country Status (24)

Country Link
US (1) US5663343A (es)
EP (1) EP0768309B1 (es)
JP (2) JP4590038B2 (es)
KR (1) KR100459745B1 (es)
CN (1) CN1060774C (es)
AT (1) ATE224896T1 (es)
AU (1) AU702594B2 (es)
CA (1) CA2187484C (es)
CZ (1) CZ288042B6 (es)
DE (1) DE69623900T2 (es)
DK (1) DK0768309T3 (es)
DZ (1) DZ2104A1 (es)
ES (1) ES2183908T3 (es)
HK (1) HK1000446A1 (es)
HU (1) HU226620B1 (es)
IL (1) IL119400A (es)
NO (1) NO307257B1 (es)
NZ (1) NZ299562A (es)
PT (1) PT768309E (es)
RU (1) RU2162085C2 (es)
SK (1) SK283471B6 (es)
TW (1) TW513423B (es)
UA (1) UA48947C2 (es)
ZA (1) ZA968525B (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19813661A1 (de) * 1997-08-01 1999-02-04 Solvay Pharm Gmbh Gegen Racemisierung stabilisierte pharmazeutische Zubereitungen von Cilansetron
US6372919B1 (en) * 2001-01-11 2002-04-16 Dov Pharmaceutical, Inc. (+)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions thereof, and uses as an anti-depressant agent
US20040048874A1 (en) * 2001-05-22 2004-03-11 Bardsley Hazel Judith New therapeutic use of 4-(2-fluorophenyl)-6-methyl-2-(1-piperazinyl)thieno[2,3-D]pyrimidine
GB0216027D0 (en) * 2002-07-10 2002-08-21 Arachnova Therapeutics Ltd New therapeutic use
US7015333B2 (en) * 2002-11-18 2006-03-21 Solvay Pharmaceuticals B.V. Process for preparation of imidazolyl compounds
EP1424337A1 (en) * 2002-11-26 2004-06-02 Solvay Pharmaceuticals GmbH 4-hydroxy derivatives of 5,6,9,10-tetrahydro-10-((2-methyl-1h-imidazol-1-yl)methyl)-4h-pyrido-(3,2,1-jk)-carbazol-11(8h)-one
AU2004204825B2 (en) * 2003-01-13 2007-07-19 Dynogen Pharmaceuticals, Inc. Method of treating functional bowel disorders
PL378369A1 (pl) * 2003-01-13 2006-04-03 Dynogen Pharmaceuticals, Inc. Sposób leczenia mdłości, wymiotów, nudności lub ich dowolnej kombinacji
AU2004227945B2 (en) * 2003-04-04 2006-10-26 Dynogen Pharmaceuticals, Inc. Method of treating lower urinary tract disorders
EP1706394B1 (en) * 2003-11-12 2014-12-17 Dr. Reddy's Laboratories, Inc. Preparation of escitalopram
US20070043100A1 (en) 2005-08-16 2007-02-22 Hagen Eric J Novel polymorphs of azabicyclohexane
US20080045725A1 (en) 2006-04-28 2008-02-21 Murry Jerry A Process For The Synthesis of (+) And (-)-1-(3,4-Dichlorophenyl)-3-Azabicyclo[3.1.0]Hexane
US7662831B2 (en) 2006-07-27 2010-02-16 Wyeth Llc Tetracyclic indoles as potassium channel modulators
US7601856B2 (en) 2006-07-27 2009-10-13 Wyeth Benzofurans as potassium ion channel modulators
JP5156222B2 (ja) * 2006-11-28 2013-03-06 エムキュア ファーマシューティカルズ リミテッド 制吐作用化合物の新たな製造方法
GB0910373D0 (en) * 2009-06-16 2009-07-29 Filtrona Int Ltd Tabacco smoke filter
US9806720B1 (en) * 2016-10-07 2017-10-31 Analog Devices Global Compound semiconductor based inverter
WO2019222565A1 (en) * 2018-05-18 2019-11-21 Kura Oncology, Inc. Synthesis of tipifarnib

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7413843A (nl) * 1974-10-23 1976-04-27 Stamicarbon Optische scheiding van fenylglycine-amide.
US4849527A (en) * 1982-09-13 1989-07-18 Bristol-Myers Company Process for resolution of optical isomers
US4463176A (en) * 1982-09-13 1984-07-31 Mead Johnson & Company Process for resolution of optical isomers
CH664152A5 (fr) * 1984-01-25 1988-02-15 Glaxo Group Ltd Derives de tetrahydrocarbazolones.
ES2059491T3 (es) * 1987-06-29 1994-11-16 Duphar Int Res Derivados de indol con anillos condensados.
GB8812636D0 (en) * 1988-05-27 1988-06-29 Glaxo Group Ltd Chemical compounds
EP0350129A1 (en) * 1988-07-07 1990-01-10 Duphar International Research B.V New annelated indoleketones with an imidazolylalkyl substituent
DE4238553A1 (de) * 1992-11-14 1994-05-19 Kali Chemie Pharma Gmbh Neue Imidazol-1-yl-Verbindungen enthaltende Arzneimittel

Also Published As

Publication number Publication date
SK283471B6 (sk) 2003-08-05
HU226620B1 (en) 2009-04-28
JP2010159292A (ja) 2010-07-22
NO964282D0 (no) 1996-10-09
DK0768309T3 (da) 2002-12-09
RU2162085C2 (ru) 2001-01-20
EP0768309B1 (en) 2002-09-25
NO307257B1 (no) 2000-03-06
EP0768309A1 (en) 1997-04-16
ATE224896T1 (de) 2002-10-15
AU6585696A (en) 1997-04-17
UA48947C2 (uk) 2002-09-16
DZ2104A1 (fr) 2002-07-22
NZ299562A (en) 1997-09-22
CA2187484A1 (en) 1997-04-14
KR100459745B1 (ko) 2005-01-26
HK1000446A1 (en) 2003-01-10
CN1060774C (zh) 2001-01-17
AU702594B2 (en) 1999-02-25
NO964282L (no) 1997-04-14
PT768309E (pt) 2003-02-28
DE69623900T2 (de) 2003-07-31
CN1160053A (zh) 1997-09-24
ES2183908T3 (es) 2003-04-01
IL119400A0 (en) 1997-01-10
JP4590038B2 (ja) 2010-12-01
HUP9602778A3 (en) 1997-08-28
TW513423B (en) 2002-12-11
HU9602778D0 (en) 1996-11-28
US5663343A (en) 1997-09-02
CZ294796A3 (en) 1997-05-14
CZ288042B6 (cs) 2001-04-11
KR970021080A (ko) 1997-05-28
SK128796A3 (en) 1997-05-07
CA2187484C (en) 2006-09-05
JPH09183779A (ja) 1997-07-15
HUP9602778A2 (en) 1997-05-28
IL119400A (en) 2000-02-29
DE69623900D1 (de) 2002-10-31

Similar Documents

Publication Publication Date Title
IL119400A0 (en) Process for the preparation of enantiomerically pure imidazolyl compounds
US5281722A (en) Preparation and use of salts of the pure enantiomers of alpha-lipoic acid
FI110776B (fi) Menetelmä substituoitujen fenyylipropionihappojen oleellisesti puhtaiden enantiomeerien valmistamiseksi
RU96120366A (ru) Способ получения энантиомерно чистых соединений имидазолила, энантиомерно чистая кислая аддитивная соль имидазолила и в-пироглутаминовой кислоты
EP0623104B1 (en) Profen resolution
CA2623355A1 (en) Resolution of .alpha.-(phenoxy) phenylacetic acid derivatives with naphthyl-alkylamines
JP2009108079A (ja) エナンチオマーに富むｎ−アシルアゼチジン−２−カルボン酸の製造方法
EP0220435B1 (en) A method for preparing optically active half esters
SK140898A3 (en) Improved process for the production of enantiomerically-pure azetidine-2-carboxylic acid
FI93833C (fi) Menetelmä propionihappojohdosten valmistamiseksi
HK1039111A1 (en) Method for producing enantiomer-free n-methyl-n-Ä(1S)-1-phenyl-2-((3S)-3- hydroxypyrrolidine-1-yl) ethylÜ-2,2-diphenyl acetamide
JPS6323824A (ja) 酸性α−水素を有するアミンの光学分割およびラセミ化方法
US4584313A (en) (Substituted-phenyl)-5-oxo-2-pyrrolidinepropanoic acids and esters thereof, and use for reversing electroconvulsive shock-induced amnesia
Schjelderup et al. The absolute configuration of oxyphencyclimine, a parasympatholytic drug. Syntheses of both enantiomers
HU205594B (en) Process for producing optical isomeres of cyclopropane-carboxylic acids5
US6166224A (en) Method for racemization of optically active azetidine-2-carboxylate
WO1990002118A1 (en) Derivatives and precursors of captopril and its analogues
DE59606235D1 (de) Synthese von optisch aktivem aminoindanol
HU202803B (en) Process for separation of optical isomers of m-phenoxymandelic acid